FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s
The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks. [Source]
Publication Date:Origin: nytimes.com
Category: Drugs (Pharmaceuticals)
Topics: risks, safety, carry, disease, stages, initial, decline, cognitive, modestly, could, treatments, class, latest, Lilly, Kisunla, Alzheimer’s, Early, Lilly’s, Donanemab, Approves
Source: https://www.nytimes.com/2024/07/02/health/alzheimers-treatment-kisunla-donanemab.html